476
Views
0
CrossRef citations to date
0
Altmetric
Oncology

Real-world total cost of care by line of therapy in relapsed/refractory diffuse large B-cell lymphoma

, , ORCID Icon, , , , & show all
Pages 738-745 | Received 05 Dec 2023, Accepted 26 Apr 2024, Published online: 06 May 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

For more information please visit our Permissions help page.